Korean Market
ISSU
ImmuneOncia Therapeutics
★
81.8 Billion Won Rights Offering Completed, Issue Price 4,860 Won, Top Shareholder Stake Diluted to 56.62%
 13h ago
EXCH
ImmuneOncia Therapeutics
★
KRW 81.8 Billion Rights Offering Fully Subscribed, 16.8M New Shares to List on June 8
 13h ago
PERI
ImmuneOncia Therapeutics
★
ImmuneOncia Q1 2026: Operating Loss Continues, Capital Raise Decided
 05/15/2026, 05:14 PM
PERI
ImmuneOncia Therapeutics
★
ImmuneOncia: No Revenue, Expanding Operating Loss in Q1 2026, Rights Offering Decided
 05/15/2026, 03:45 PM
EXCH
ImmuneOncia Therapeutics
★★
Rights offering oversubscribed at 104.29%
 05/15/2026, 02:32 PM
ISSU
ImmuneOncia Therapeutics
★★
ImmuneOncia Rights Offering: Final Price at 4,860 Won, Raising ₩81.8B for IMC-001 Commercialization
 05/11/2026, 04:40 PM
ISSU
ImmuneOncia Therapeutics
★★
ImmuneOncia Finalizes 81.8 Billion Won Rights Offering at 4,860 Won for IMC-001 Commercialization
 05/11/2026, 04:34 PM
MATR
ImmuneOncia Therapeutics
★★
Rights Offering: 105.4B Won for Operations, Issue Price 4,860 Won
 05/11/2026, 03:40 PM
EXCH
ImmuneOncia Therapeutics
★★
Rights Offering Final Price Set at 4,860 Won
 05/08/2026, 05:04 PM
OWNR
ImmuneOncia Therapeutics
★
Large Shareholding Report Filed (No Specifics)
 05/03/2026, 07:00 AM